New Report Examines Post-Market Safety Surveillance For Drugs, Vaccines

“To fight many of the diseases that plague the world’s poorest, we need tools — safe and effective drugs and vaccines that can reduce unnecessary suffering and afford millions the opportunity to lead healthy and productive lives. An essential part of having the right tools, and making sure that the right patients are getting and using them in the right way, is post-market safety surveillance…,” Trevor Mundel, president of Global Health at the Bill & Melinda Gates Foundation, writes in the foundation’s “Impatient Optimists” blog. He highlights a Gates Foundation-supported report (.pdf), titled “Strengthening Post-Market Safety Surveillance in Low- and Middle-Income Countries.” He concludes, “This report represents innovative thinking in the field and has provided us with a plan for moving forward. Now it is our responsibility to work together on making it a reality” (2/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.